iRhythm Q4 revenue $112.6M (+37.7% YoY); adjusted EBITDA positive $1.1M; guides 2023 rev $475-485M

iRhythm Holdings, Inc.

2022-FY EPS reported -$3.88 revenue$410,921,000

Q4 revenue $112.6M (+37.7% YoY); gross margin 69.9% (up 720 bps); net loss $20.2M ($0.67 loss per share) vs $32.5M loss in Q4 2021.
Q4 adjusted EBITDA $1.1M, first positive quarter; full year adjusted EBITDA -$11.3M, improvement of $24.4M YoY.
Full year 2022 revenue $410.9M (+27.3% YoY); net loss $116.2M ($3.88 loss per share) vs $101.4M loss in 2021.
2023 guidance: revenue $475-485M (16-18% growth); gross margin 69-70%; adjusted EBITDA margin -0.5% to 0.5%.
Operational: CMS Final Rule with national CPT rates; FDA clearance for ZEUS system update; health economic data presented at AHA.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

iRhythm Holdings, Inc. updated its the fourth quarter and full year ended December 31, 2022 guidance (initiated).

Period: the fourth quarter and full year ended December 31, 2022
Guidance: initiated
Result: reported results

Exact text from the filing

On February 23, 2023, iRhythm Technologies, Inc. issued a press release regarding its financial results for the fourth quarter and full year ended December 31, 2022.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

iRhythm Holdings, Inc. reported year ended December 31, 2022 results: revenue $410.9 million, net income $116.2 million, EPS $3.88 per share. Guidance initiated.

Period: year ended December 31, 2022
Revenue: $410.9 million
Net income: $116.2 million
EPS: $3.88 per share
Guidance: initiated
Result: reported results

Exact text from the filing

equivalents and short-term investments of $213.1 million at December 31, 2022, a $9.6 million increase from September 30, 2022 Full Year 2022 Financial Highlights • Revenue of $410.9 million, a 27.3% increase compared to full year 2021 • Gross margin of 68.5%, a 238 basis point increase compared to full year 2021 • Net loss of $116.2 million, reflecting an increase

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

iRhythm Holdings, Inc. reported the three months and full year ended December 31, 2022 results: revenue $112.6 million, net income $20.2 million, EPS $0.67 per share. Guidance initiated.

Period: the three months and full year ended December 31, 2022
Revenue: $112.6 million
Net income: $20.2 million
EPS: $0.67 per share
Guidance: initiated
Result: reported results

Exact text from the filing

predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights • Revenue of $112.6 million, a 37.7% increase compared to fourth quarter 2021 • Gross margin of 69.9%, a 720 basis point improvement compared to fourth quarter 2021 • Net loss of $20.2 million, a $12.3

View on SEC.gov

Browse all earnings releases →

iRhythm Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001388658-23-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.